DICERNA PHARMACEUTICALS

dicerna-pharmaceuticals-logo

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others. The company was founded in 2007 and is headquartered in Lexington, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

DICERNA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Genetics Health Care Pharmaceutical

Founded:
2007-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.dicerna.com

Total Employee:
101+

Status:
Closed

Contact:
6176126254

Email Addresses:
[email protected]

Total Funding:
271.45 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Sitelinks Search Box


Similar Organizations

a2a-pharmaceuticals-logo

A2A Pharmaceuticals

A2A Pharmaceuticals is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents.

accera-logo

Accera

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

adcentrx-therapeutics-logo

Adcentrx Therapeutics

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

applied-genetics-technologies-corporation-logo

Applied Genetics Technologies Corporation

AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.

aridis-pharmaceuticals-logo

Aridis Pharmaceuticals

Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

biophytis-logo

Biophytis

Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.

biosystems-international-logo

Biosystems International

Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.

cardiofocus-logo

CardioFocus

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

not_available_image

Emerillon Therapeutics

Emerillon therapeutics is a biotechnology firm focused on the creation of innovative drug products for the treatment of infectious disease.

equitech-therapeutics-llc-logo

EquiTech Therapeutics, LLC

EquiTech Therapeutics, LLC's is a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and therapies.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

genecure-logo

Genecure

GeneCure is a biotechnology company providing treatments for life-threatening human diseases.

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

magicmed-industries-logo

MagicMed Industries

MagicMed Industries is a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

parabase-genomics-logo

Parabase Genomics

Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.

regeneron-logo

Regeneron

Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

vaccinex-logo

Vaccinex

Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.

verenium-logo

Verenium

Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.

vision-genomics-logo

Vision Genomics

Vision genomics, LLC is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases.

zabecor-pharmaceuticals-logo

ZaBeCor Pharmaceuticals

ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular


Current Advisors List

stephen-j-hoffman_image

Stephen J. Hoffman Board of Directors @ Dicerna Pharmaceuticals
Board_member
2007-10-01

cynthia-smith_image

Cynthia Smith Member Board Of Directors @ Dicerna Pharmaceuticals
Board_member
2018-01-01

brian-halak_image

Brian Halak Member of Board of Directors @ Dicerna Pharmaceuticals
Board_member

adam-koppel_image

Adam Koppel Board of Directors @ Dicerna Pharmaceuticals
Board_member

stephen-k-doberstein_image

Stephen K. Doberstein Independent Board Member @ Dicerna Pharmaceuticals
Board_member
2020-03-01

Current Employees Featured

douglas-fambrough_image

Douglas Fambrough
Douglas Fambrough CEO @ Dicerna Pharmaceuticals
CEO

rob-ciappenelli_image

Rob Ciappenelli
Rob Ciappenelli Chief Strategy Officer @ Dicerna Pharmaceuticals
Chief Strategy Officer
2021-09-01

marc-abrams_image

Marc Abrams
Marc Abrams Senior Vice President, Discovery Research @ Dicerna Pharmaceuticals
Senior Vice President, Discovery Research
2021-09-01

not_available_image

Cheng Lai
Cheng Lai Executive Director @ Dicerna Pharmaceuticals
Executive Director
2013-10-01

regina-detore-paglia_image

Regina DeTore Paglia
Regina DeTore Paglia Chief Human Resources Officer @ Dicerna Pharmaceuticals
Chief Human Resources Officer
2019-02-01

bob-d-brown_image

Bob D. Brown
Bob D. Brown CSO, SVP Research and Development @ Dicerna Pharmaceuticals
CSO, SVP Research and Development
2016-01-01

emma-wright_image

Emma Wright
Emma Wright Senior Director, Manufacturing @ Dicerna Pharmaceuticals
Senior Director, Manufacturing

kristen-k-sheppard-esq_image

Kristen K. Sheppard, Esq.
Kristen K. Sheppard, Esq. SVP, Investor Relations & Corporate Communications @ Dicerna Pharmaceuticals
SVP, Investor Relations & Corporate Communications
2021-09-01

Founder


jim-jenson_image

Jim Jenson

Stock Details


Company's stock symbol is NASDAQ:DRNA

Investors List

eli-lilly_image

Eli Lilly

Eli Lilly investment in Post-IPO Equity - Dicerna Pharmaceuticals

cowen-group_image

Cowen Group

Cowen Group investment in Post-IPO Equity - Dicerna Pharmaceuticals

skyline-ventures_image

Skyline Ventures

Skyline Ventures investment in Post-IPO Debt - Dicerna Pharmaceuticals

domain-associates_image

Domain Associates

Domain Associates investment in Post-IPO Debt - Dicerna Pharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Debt - Dicerna Pharmaceuticals

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Post-IPO Debt - Dicerna Pharmaceuticals

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Post-IPO Debt - Dicerna Pharmaceuticals

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Post-IPO Debt - Dicerna Pharmaceuticals

abingworth-management_image

Abingworth

Abingworth investment in Series C - Dicerna Pharmaceuticals

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Series C - Dicerna Pharmaceuticals

Official Site Inspections

http://www.dicerna.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.94 K

  • Host name: 199.47.130.30
  • IP address: 199.47.130.30
  • Location: Dallas United States
  • Latitude: 32.7767
  • Longitude: -96.805
  • Metro Code: 623
  • Timezone: America/Chicago
  • Postal: 75202

Loading ...

More informations about "Dicerna Pharmaceuticals" on Search Engine